Continuing Education
for Urology & GU Oncology Clinicians

Conference Coverage: SUO 2019 Bladder

Washington, DC (UroToday.com) Organ preservation in bladder cancer has been a widely debated topic with polarizing views from different centers and researchers worldwide. At the SUO 2019 meeting in Washington, DC, during the session on organ preservation in urologic cancers, Professor Robert Huddart from the Royal Marsden presented on Muscle-invasive bladder cancer (MIBC). 

Non-Accredited

Washington, DC (UroToday.com) While direct patient care, ranging from consultation to counseling and surgical intervention, is foremost for the vast majority of urologists and urologic oncologists, we may arguably benefit more patients and have a greater influence through clinical research by advancing the state of knowledge used to inform the care of patients well beyond our direct clinical research. Previous work from the Society of Urologic Oncology (SUO) has identified the lack of structured education in clinical research and clinical trial design and involvement as a weakness for many physicians graduating from SUO accredited fellowships. To this end, the SUO convened a Symposium on Clinical Research and Clinical Trials in conjunction with their annual meeting. 

Non-Accredited

Washington, DC (UroToday.com)  While direct patient care, ranging from consultation to counseling and surgical intervention, is foremost for the vast majority of urologists and urologic oncologists, we may arguably benefit more patients and have a greater influence through clinical research by advancing the state of knowledge used to inform the care of patients well beyond our direct clinical research. Previous work from the Society of Urologic Oncology (SUO) has identified the lack of structured education in clinical research and clinical trial design and involvement as a weakness for many physicians graduating from the Society of Urologic Oncology accredited fellowships. To this end, the SUO convened a Symposium on Clinical Research and Clinical Trials in conjunction with this year’s annual meeting.

Non-Accredited

Washington, DC (UroToday.com) As part of the Research Scholars Update at the 20th Annual Meeting of the Society of Urologic Oncology, Dr. Karen Wheeler presented her work on immunotherapy and bladder cancer. Previous work has shown that surgery can induce an immune suppressive state. Using a mouse model, Dr. Wheeler assessed survival of mice with intravenous MB49 (lung metastasis) or intravesical MB49 (orthotopic) demonstrating that surgery can worsen survival in the metastatic model but not in an orthotopic (bladder cancer) model:

Non-Accredited

Washington, DC (UroToday.com) Upper tract urothelial carcinoma (UTUC) represents a challenging diagnostic entity for a urologist with definitive diagnosis requires invasive procedures. These procedures are required throughout the life cycle of the disease for surveillance unless the kidney and ureter are completely removed.

Non-Accredited